Neuroblastoma

'Disappearing' tumor study could lead to new cancer treatments

Published in Cancer Weekly, June 24th, 2003

A research study at the University of Nottingham looking at how growth can contribute to spontaneous childhood cancer regression could lead to more effective ways of treating tumors.

The 1-year project, led by Christopher Jones in the School of Nursing in collaboration with Dr. Michael Symonds in the division of child health and Dr. David Walker at the University's Children's Brain Tumor Research Centre, will look at whether growth hormone plays a part in tumors spontaneously getting better.

The researchers are looking at neuroblastoma, which accounts for around 6% of all childhood cancers. Around 100 children develop neuroblastoma each year in the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2003-06-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry